Phibro Animal Health | PAHC - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Align Technology USD 441.68M 23.88M 2025-12
ANI Pharmaceuticals USD 82.79M 6.13M 2025-12
Assertio Holdings USD 16.73M 1.66M 2024-09
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Corcept Therapeutics USD 114.74M 7.77M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Henry Schein USD 808M 48M 2025-12
Idexx Laboratories USD 275.68M 10.58M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Merck USD 2.85B 215M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pacira USD 91.87M 70K 2025-12
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 29.67M 1.64M 2025-12
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
Zoetis USD 619M 40M 2025-12